Medium materiality6/10
Jazz Pharmaceuticals price target raised to $281 from $264 at Truist
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises JAZZ target to $281; posted price $257.04; price change since signal +0.14%.
- Truist raises JAZZ tgt to 281 from 264; price 257.04 (+0.14)
Key facts
- 01
Target: $281
- 02
Posted price: $257.04
- 03
Analyst firm: Truist Financial
- 04
Analyst: Gregory Renza
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.